Nε-(Carboxymethyl)lysine Protein Adduct Is a Major Immunological Epitope in Proteins Modified with Advanced Glycation End Products of the Maillard Reaction
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 35 (24) , 8075-8083
- https://doi.org/10.1021/bi9530550
Abstract
Long-term incubation of proteins with glucose leads to the formation of advanced glycation end products (AGE). Recent immunological studies have suggested the potential role of AGE in atherosclerosis, aging, and diabetic complications. We previously prepared a monoclonal (6D12) as well as a polyclonal anti-AGE antibody and proposed the presence of a common AGE structure(s) that may act as a major immunochemical epitope [Horiuchi, S., Araki, N., & Morino, Y. (1991) J. Biol. Chem. 266, 7329−7332]. The purpose of the present study was to determine the major epitope. Amino acid analysis of AGE−proteins indicated that Nε-(carboxymethyl)lysine (CML) was a major modified lysine residue. Immunologic studies demonstrated the positive reaction of 6D12 not only to all CML-modified proteins tested, but also to BSA modified with several aldehydes known to generate a CML−protein adduct, and a linear correlation between the CML contents of CML-BSA and their immunoreactivity to 6D12 up to ∼8 mol/mol of protein. Further experiments with CML analogs revealed that the epitope of 6D12 is a CML−protein adduct with an important carbonyl group. In contrast to 6D12, our polyclonal anti-AGE antibody showed a significant but much weaker immunoreactivity to CML-BSA, suggesting that the polyclonal antibody contains two populations, one reactive to CML (CML-PA) and the other unreactive to CML (Non-CML-PA). Non-CML-PA separated from CML-PA by CML-BSA affinity chromatography did not react with all CML-modified preparations, but retained its property to react commonly with AGE preparations obtained from proteins, lysine derivatives, and monoaminocarboxylic acids. Therefore, it is clear that a CML−protein adduct is a major immunological epitope in AGE structures, but there still exist other major epitope(s) expressed commonly in AGE−proteins.Keywords
This publication has 11 references indexed in Scilit:
- Endocytic uptake of nonenzymatically glycosylated proteins is mediated by a scavenger receptor for aldehyde-modified proteins.Published by Elsevier ,2021
- Macrophage Scavenger Receptor Mediates the Endocytic Uptake and Degradation of Advanced Glycation End Products of the Maillard ReactionEuropean Journal of Biochemistry, 1995
- Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard ReactionJournal of Biological Chemistry, 1995
- Immunochemical detection of advanced glycosylation end products in vivo.Journal of Biological Chemistry, 1992
- Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins.The Journal of Experimental Medicine, 1991
- Isolation of apolipoprotein A-I-containing lipoproteins by immunoaffinity chromatography using a formylated derivative of cellulose gelClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors.The Journal of Experimental Medicine, 1986
- Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein.Journal of Biological Chemistry, 1986
- Measurement of protein using bicinchoninic acidAnalytical Biochemistry, 1985
- On the Alkylation of Amino Acid Residues at the Active Site of RibonucleaseJournal of Biological Chemistry, 1966